David Cachia

1.6k total citations
59 papers, 738 citations indexed

About

David Cachia is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, David Cachia has authored 59 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in David Cachia's work include Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (11 papers) and Meningioma and schwannoma management (9 papers). David Cachia is often cited by papers focused on Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (11 papers) and Meningioma and schwannoma management (9 papers). David Cachia collaborates with scholars based in United States, Israel and United Kingdom. David Cachia's co-authors include Carlos Kamiya-Matsuoka, Jacob Mandel, John de Groot, Arabinda Das, Sunil J. Patel, Shlomit Yust‐Katz, Mark R. Gilbert, William A. Vandergrift, Diane Liu and Terri S. Armstrong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

David Cachia

55 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Cachia United States 16 401 215 157 157 139 59 738
Terri Chew United States 5 358 0.9× 189 0.9× 203 1.3× 151 1.0× 64 0.5× 5 857
Nicholas G. Avgeropoulos United States 10 418 1.0× 179 0.8× 234 1.5× 113 0.7× 90 0.6× 19 711
Yanhui Liu China 16 244 0.6× 141 0.7× 298 1.9× 97 0.6× 114 0.8× 101 884
Takeshi Takayasu Japan 20 564 1.4× 176 0.8× 228 1.5× 157 1.0× 209 1.5× 69 1.0k
Eric Burton United States 14 404 1.0× 205 1.0× 207 1.3× 104 0.7× 126 0.9× 41 784
Yuriko Minn United States 4 578 1.4× 233 1.1× 341 2.2× 167 1.1× 117 0.8× 5 997
Andreana L. Rivera United States 15 312 0.8× 125 0.6× 238 1.5× 118 0.8× 413 3.0× 36 974
Taku Homma Japan 14 231 0.6× 138 0.6× 189 1.2× 62 0.4× 157 1.1× 62 601
Aria Jamshidi United States 11 210 0.5× 78 0.4× 120 0.8× 64 0.4× 83 0.6× 44 524
Eva María Corrales-García Spain 7 375 0.9× 118 0.5× 270 1.7× 94 0.6× 45 0.3× 12 754

Countries citing papers authored by David Cachia

Since Specialization
Citations

This map shows the geographic impact of David Cachia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cachia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cachia more than expected).

Fields of papers citing papers by David Cachia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cachia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cachia. The network helps show where David Cachia may publish in the future.

Co-authorship network of co-authors of David Cachia

This figure shows the co-authorship network connecting the top 25 collaborators of David Cachia. A scholar is included among the top collaborators of David Cachia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cachia. David Cachia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boele, Florien, Caroline Hertler, Paula R. Sherwood, et al.. (2024). Reporting standards in randomized controlled trials involving neuro-oncology caregivers: A systematic review report from the RANO-Cares working group. Neuro-Oncology Practice. 12(1). 19–33. 2 indexed citations
2.
Nghiemphu, Phioanh L., Jérémie Vitte, Eva Dombi, et al.. (2024). Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of Neuro-Oncology. 167(2). 339–348. 2 indexed citations
3.
Mietus, Constance J., et al.. (2023). Diffusely invasive supratentorial rosette-forming glioneuronal tumor: illustrative case. Journal of Neurosurgery Case Lessons. 6(16). 4 indexed citations
4.
5.
Das, Arabinda, Mohammed Alshareef, Guilherme Porto, et al.. (2020). Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations. Clinical & Translational Oncology. 22(11). 2017–2025. 14 indexed citations
6.
Das, Arabinda, Mohammed Alshareef, Guilherme Porto, et al.. (2020). Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment. Journal of the Neurological Sciences. 418. 117102–117102. 4 indexed citations
7.
Das, Arabinda, Mohammed Alshareef, Fraser Henderson, et al.. (2019). Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clinical & Translational Oncology. 22(7). 1138–1145. 23 indexed citations
8.
Harrison, Rebecca A., Mark D. Anderson, David Cachia, et al.. (2019). Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. European Journal of Cancer. 112. 83–93. 14 indexed citations
9.
Ajinkya, Shaun, Alain Lekoubou, Scott Lindhorst, et al.. (2019). Clinical characteristics, EEG findings and implications of status epilepticus in patients with brain metastases. Journal of the Neurological Sciences. 407. 116538–116538. 2 indexed citations
10.
Chalela, Julio A., et al.. (2018). Multi Cranial Neuropathy Secondary To Primary Glioblastoma Of Trigeminal Nerve: Case Report (P6.116). Neurology. 90(15_supplement). 1 indexed citations
11.
Mandel, Jacob, Shlomit Yust‐Katz, Akash J. Patel, et al.. (2017). Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma. Neuro-Oncology. 20(1). 113–122. 55 indexed citations
12.
Cachia, David, Carlos Kamiya-Matsuoka, Adriana Olar, et al.. (2017). Ependymomas arising outside of the central nervous system: A case series and literature review. Journal of Clinical Neuroscience. 47. 202–207. 21 indexed citations
13.
Cachia, David, Nabil Elshafeey, Carlos Kamiya-Matsuoka, et al.. (2017). Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. Journal of Neuro-Oncology. 135(1). 75–81. 14 indexed citations
14.
Mandel, Jacob, David Cachia, Diane Liu, et al.. (2016). Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. Journal of Neuro-Oncology. 129(1). 147–154. 30 indexed citations
15.
Kamiya-Matsuoka, Carlos, David Cachia, Steven G. Waguespack, et al.. (2016). Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 19(4). 415–421. 17 indexed citations
16.
Gatson, Na Tosha, Clement Pillainayagam, David Cachia, et al.. (2016). Gliomatosis, to Be or Not to Cerebri? (P6.299). Neurology. 86(16_supplement).
17.
18.
Kamiya-Matsuoka, Carlos, et al.. (2015). Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer Center. Journal of Neuro-Oncology. 125(1). 143–148. 21 indexed citations
19.
Cachia, David, Carlos Kamiya-Matsuoka, Jacob Mandel, et al.. (2015). Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. Journal of Neuro-Oncology. 125(2). 401–410. 53 indexed citations
20.
Cachia, David, Joan M. Swearer, Warren J. Ferguson, & Majaz Moonis. (2011). Selective cognitive patterns resulting from bilateral hippocampal ischemia. Archives of Medical Science. 1(1). 168–172. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026